| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.679 | 0.003 | 0.829 | Cyclic AMP phosphodiesterase inhibitor | 0.697 0.003 DBMET02750 0.722 0.003 DBMET02753 0.667 0.004 DBMET02754 0.709 0.003 DBMET02755 0.368 0.022 DBMET02751 0.829 0.002 DBMET02752 | DBMET02752 | |
| 0.605 | 0.004 | 0.651 | MAO B inhibitor | 0.636 0.004 DBMET02750 0.622 0.004 DBMET02753 0.651 0.004 DBMET02754 0.564 0.004 DBMET02755 0.205 0.024 DBMET02751 | DBMET02754 | |
| 0.605 | 0.005 | 0.653 | MAO inhibitor | 0.65 0.005 DBMET02750 0.609 0.005 DBMET02753 0.653 0.005 DBMET02754 0.536 0.006 DBMET02755 0.24 0.03 DBMET02751 | DBMET02754 | |
| 0.588 | 0.017 | 0.627 | Vasodilator, peripheral | 0.618 0.014 DBMET02750 0.617 0.014 DBMET02753 0.579 0.018 DBMET02754 0.605 0.015 DBMET02755 0.267 0.115 DBMET02751 0.627 0.013 DBMET02752 | DBMET02752 | |
| 0.559 | 0.003 | 0.559 | Adenosine A2 receptor antagonist | 0.48 0.003 DBMET02750 0.423 0.004 DBMET02753 0.555 0.003 DBMET02754 0.475 0.003 DBMET02755 0.248 0.007 DBMET02751 0.128 0.02 DBMET02752 | ||
| 0.537 | 0.003 | 0.537 | Adenosine A2a receptor antagonist | 0.479 0.003 DBMET02750 0.408 0.004 DBMET02753 0.536 0.003 DBMET02754 0.451 0.003 DBMET02755 0.25 0.007 DBMET02751 0.143 0.016 DBMET02752 | ||
| 0.495 | 0.003 | 0.573 | Adenosine A1 receptor antagonist | 0.456 0.004 DBMET02750 0.419 0.004 DBMET02753 0.573 0.003 DBMET02754 0.448 0.004 DBMET02755 0.323 0.006 DBMET02751 0.306 0.006 DBMET02752 | DBMET02754 | |
| 0.455 | 0.005 | 0.455 | Phosphodiesterase inhibitor | 0.363 0.009 DBMET02750 0.33 0.012 DBMET02753 0.322 0.012 DBMET02754 0.383 0.008 DBMET02755 0.232 0.026 DBMET02751 0.214 0.031 DBMET02752 | ||
| 0.444 | 0.005 | 0.444 | Bronchodilator | 0.418 0.005 DBMET02750 0.373 0.006 DBMET02753 0.416 0.005 DBMET02754 0.381 0.006 DBMET02755 0.311 0.008 DBMET02751 0.308 0.009 DBMET02752 | ||
| 0.515 | 0.078 | 0.594 | DNA directed DNA polymerase inhibitor | 0.58 0.061 DBMET02750 0.594 0.057 DBMET02753 0.549 0.069 DBMET02754 0.531 0.073 DBMET02755 0.252 0.19 DBMET02752 | DBMET02753 | |
| 0.472 | 0.038 | 0.479 | Toll-Like receptor 7 agonist | 0.431 0.049 DBMET02750 0.416 0.054 DBMET02753 0.454 0.042 DBMET02754 0.45 0.043 DBMET02755 0.286 0.119 DBMET02751 0.479 0.036 DBMET02752 | DBMET02752 | |
| 0.464 | 0.04 | 0.486 | Toll-Like receptor agonist | 0.424 0.051 DBMET02750 0.413 0.055 DBMET02753 0.445 0.045 DBMET02754 0.447 0.044 DBMET02755 0.294 0.115 DBMET02751 0.486 0.034 DBMET02752 | DBMET02752 | |
| 0.389 | 0.039 | 0.595 | Vasodilator, coronary | 0.406 0.033 DBMET02750 0.433 0.026 DBMET02753 0.354 0.053 DBMET02754 0.419 0.029 DBMET02755 0.595 0.008 DBMET02752 | DBMET02752 | |
| 0.341 | 0.003 | 0.341 | Adenosine A2b receptor antagonist | 0.258 0.004 DBMET02750 0.248 0.004 DBMET02753 0.306 0.003 DBMET02754 0.294 0.004 DBMET02755 0.106 0.009 DBMET02751 | ||
| 0.343 | 0.011 | 0.343 | Tumour necrosis factor antagonist | 0.312 0.016 DBMET02750 0.238 0.035 DBMET02753 0.21 0.048 DBMET02754 0.257 0.029 DBMET02755 0.158 0.09 DBMET02752 | ||
| 0.322 | 0.004 | 0.322 | Phosphodiesterase 5A inhibitor | 0.261 0.005 DBMET02750 0.283 0.005 DBMET02753 0.284 0.005 DBMET02754 0.318 0.004 DBMET02755 0.195 0.006 DBMET02751 0.129 0.016 DBMET02752 | ||
| 0.311 | 0.004 | 0.311 | Phosphodiesterase V inhibitor | 0.253 0.005 DBMET02750 0.273 0.005 DBMET02753 0.274 0.005 DBMET02754 0.306 0.004 DBMET02755 0.187 0.007 DBMET02751 0.123 0.018 DBMET02752 | ||
| 0.416 | 0.113 | 0.468 | DNA polymerase beta inhibitor | 0.468 0.095 DBMET02750 0.408 0.116 DBMET02753 0.414 0.113 DBMET02754 0.346 0.141 DBMET02755 | DBMET02750 | |
| 0.348 | 0.051 | 0.435 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.435 0.03 DBMET02750 0.306 0.063 DBMET02753 0.385 0.041 DBMET02754 0.21 0.094 DBMET02755 | DBMET02750 | |
| 0.379 | 0.106 | 0.379 | Beta lactamase inhibitor | 0.248 0.158 DBMET02750 0.196 0.188 DBMET02753 0.202 0.184 DBMET02754 0.275 0.145 DBMET02755 0.356 0.113 DBMET02751 | ||
| 0.273 | 0.006 | 0.273 | Phosphodiesterase IV inhibitor | 0.187 0.015 DBMET02750 0.167 0.018 DBMET02753 0.072 0.07 DBMET02754 0.23 0.009 DBMET02755 | ||
| 0.336 | 0.074 | 0.336 | Thyroid hormone beta antagonist | 0.331 0.075 DBMET02750 0.267 0.107 DBMET02753 0.303 0.086 DBMET02754 0.257 0.114 DBMET02755 | ||
| 0.267 | 0.006 | 0.271 | Adenosine A3 receptor antagonist | 0.229 0.008 DBMET02750 0.157 0.012 DBMET02753 0.271 0.006 DBMET02754 0.193 0.009 DBMET02755 0.091 0.032 DBMET02751 0.119 0.018 DBMET02752 | DBMET02754 | |
| 0.259 | 0.006 | 0.301 | Phosphodiesterase I inhibitor | 0.225 0.008 DBMET02750 0.279 0.005 DBMET02753 0.199 0.011 DBMET02754 0.301 0.005 DBMET02755 0.086 0.064 DBMET02751 | DBMET02755 | |
| 0.32 | 0.084 | 0.329 | Thyroid hormone antagonist | 0.329 0.081 DBMET02750 0.262 0.116 DBMET02753 0.306 0.09 DBMET02754 0.246 0.126 DBMET02755 | DBMET02750 | |
| 0.23 | 0.004 | 0.307 | Phosphodiesterase VI inhibitor | 0.219 0.004 DBMET02750 0.305 0.003 DBMET02753 0.191 0.005 DBMET02754 0.307 0.003 DBMET02755 0.127 0.01 DBMET02751 0.264 0.004 DBMET02752 | DBMET02755 | |
| 0.244 | 0.022 | 0.244 | Toll-Like receptor 9 antagonist | 0.187 0.041 DBMET02750 0.17 0.051 DBMET02753 0.152 0.061 DBMET02754 0.189 0.041 DBMET02755 | ||
| 0.246 | 0.03 | 0.246 | Cytidine deaminase inhibitor | 0.218 0.039 DBMET02750 0.205 0.045 DBMET02753 0.215 0.041 DBMET02754 0.225 0.037 DBMET02755 | ||
| 0.266 | 0.054 | 0.344 | Antimitotic | 0.286 0.048 DBMET02750 0.252 0.059 DBMET02753 0.174 0.101 DBMET02754 0.223 0.072 DBMET02755 0.344 0.034 DBMET02751 0.165 0.108 DBMET02752 | DBMET02751 | |
| 0.265 | 0.061 | 0.38 | Vasodilator | 0.294 0.05 DBMET02750 0.29 0.051 DBMET02753 0.292 0.051 DBMET02754 0.266 0.061 DBMET02755 0.38 0.027 DBMET02752 | DBMET02752 | |
| 0.199 | 0.011 | 0.199 | Phosphodiesterase 4D inhibitor | 0.16 0.017 DBMET02750 0.125 0.026 DBMET02753 0.1 0.037 DBMET02754 0.148 0.02 DBMET02755 0.083 0.045 DBMET02751 0.118 0.029 DBMET02752 | ||
| 0.187 | 0.009 | 0.187 | Phosphodiesterase 4B inhibitor | 0.106 0.023 DBMET02750 0.098 0.026 DBMET02753 0.155 0.012 DBMET02755 | ||
| 0.169 | 0.005 | 0.169 | Phosphodiesterase 4C inhibitor | 0.124 0.01 DBMET02750 0.091 0.017 DBMET02753 0.088 0.018 DBMET02754 0.119 0.011 DBMET02755 0.091 0.017 DBMET02751 0.096 0.016 DBMET02752 | ||
| 0.262 | 0.121 | 0.329 | Prostaglandin dehydrogenase inhibitor | 0.316 0.095 DBMET02750 0.246 0.129 DBMET02753 0.329 0.09 DBMET02754 0.191 0.163 DBMET02755 | DBMET02754 | |
| 0.181 | 0.044 | 0.214 | Tubulin antagonist | 0.214 0.033 DBMET02750 0.176 0.046 DBMET02753 0.117 0.083 DBMET02754 0.141 0.063 DBMET02755 0.187 0.041 DBMET02751 | DBMET02750 | |
| 0.137 | 0.005 | 0.137 | Phosphodiesterase 1A inhibitor | 0.092 0.012 DBMET02750 0.1 0.01 DBMET02753 0.108 0.008 DBMET02754 0.129 0.006 DBMET02755 0.055 0.054 DBMET02751 | ||
| 0.159 | 0.029 | 0.176 | Heat shock protein 70 antagonist | 0.176 0.014 DBMET02750 0.156 0.034 DBMET02753 0.176 0.014 DBMET02754 0.145 0.059 DBMET02755 0.171 0.017 DBMET02752 | DBMET02754 | |
| 0.229 | 0.101 | 0.403 | Spasmolytic | 0.287 0.075 DBMET02750 0.359 0.05 DBMET02753 0.271 0.082 DBMET02754 0.319 0.063 DBMET02755 0.403 0.039 DBMET02752 | DBMET02752 | |
| 0.203 | 0.078 | 0.22 | Psychostimulant | 0.195 0.082 DBMET02750 0.146 0.12 DBMET02753 0.22 0.07 DBMET02754 0.153 0.113 DBMET02755 0.199 0.081 DBMET02752 | DBMET02754 | |
| 0.137 | 0.014 | 0.233 | Phosphodiesterase 6D inhibitor | 0.147 0.01 DBMET02750 0.176 0.005 DBMET02753 0.166 0.007 DBMET02754 0.164 0.007 DBMET02755 0.109 0.038 DBMET02751 0.233 0.004 DBMET02752 | DBMET02752 | |
| 0.131 | 0.011 | 0.131 | Phosphodiesterase 4A inhibitor | 0.089 0.018 DBMET02750 0.074 0.023 DBMET02753 0.045 0.038 DBMET02754 0.093 0.017 DBMET02755 0.047 0.037 DBMET02751 0.066 0.026 DBMET02752 | ||
| 0.12 | 0.014 | 0.144 | TRPA1 antagonist | 0.081 0.025 DBMET02750 0.144 0.01 DBMET02754 | DBMET02754 | |
| 0.274 | 0.17 | 0.274 | Transcription factor inhibitor | 0.26 0.18 DBMET02750 0.234 0.198 DBMET02754 | ||
| 0.141 | 0.04 | 0.238 | DNA repair enzyme inhibitor | 0.143 0.038 DBMET02750 0.128 0.058 DBMET02753 0.143 0.038 DBMET02754 0.128 0.058 DBMET02755 0.238 0.006 DBMET02752 | DBMET02752 | |
| 0.112 | 0.012 | 0.148 | Phosphodiesterase 1B inhibitor | 0.084 0.02 DBMET02750 0.115 0.011 DBMET02753 0.075 0.026 DBMET02754 0.148 0.007 DBMET02755 | DBMET02755 | |
| 0.129 | 0.031 | 0.133 | Phosphodiesterase 7B inhibitor | 0.103 0.053 DBMET02750 0.115 0.041 DBMET02753 0.1 0.056 DBMET02754 0.133 0.029 DBMET02755 0.084 0.08 DBMET02751 | DBMET02755 | |
| 0.292 | 0.203 | 0.346 | Caspase 9 stimulant | 0.346 0.149 DBMET02750 0.324 0.169 DBMET02753 0.275 0.223 DBMET02754 0.28 0.217 DBMET02755 0.303 0.19 DBMET02752 | DBMET02750 | |
| 0.157 | 0.072 | 0.319 | Diuretic | 0.156 0.072 DBMET02750 0.154 0.074 DBMET02753 0.242 0.032 DBMET02754 0.163 0.067 DBMET02755 0.183 0.052 DBMET02751 0.319 0.019 DBMET02752 | DBMET02752 | |
| 0.153 | 0.071 | 0.203 | Acetylcholine M1 receptor antagonist | 0.157 0.069 DBMET02750 0.168 0.06 DBMET02753 0.203 0.041 DBMET02754 0.163 0.064 DBMET02755 | DBMET02754 | |
| 0.175 | 0.096 | 0.278 | Pyruvate kinase inhibitor | 0.278 0.054 DBMET02750 0.143 0.122 DBMET02753 0.272 0.055 DBMET02754 | DBMET02750 | |
| 0.077 | 0.004 | 0.077 | Phosphodiesterase 6C inhibitor | 0.071 0.004 DBMET02750 0.069 0.005 DBMET02753 0.077 0.004 DBMET02754 0.072 0.004 DBMET02755 0.066 0.005 DBMET02751 0.059 0.009 DBMET02752 | ||
| 0.075 | 0.004 | 0.075 | Phosphodiesterase 6B inhibitor | 0.063 0.005 DBMET02750 0.061 0.005 DBMET02753 0.075 0.004 DBMET02754 0.067 0.004 DBMET02755 0.056 0.005 DBMET02751 0.033 0.018 DBMET02752 | ||
| 0.123 | 0.056 | 0.229 | Cystathionine beta-synthase inhibitor | 0.203 0.024 DBMET02750 0.137 0.047 DBMET02753 0.229 0.018 DBMET02754 0.097 0.08 DBMET02755 0.134 0.049 DBMET02752 | DBMET02754 | |
| 0.115 | 0.053 | 0.319 | Mediator release inhibitor | 0.134 0.036 DBMET02750 0.136 0.036 DBMET02753 0.141 0.033 DBMET02754 0.12 0.047 DBMET02755 0.319 0.006 DBMET02752 | DBMET02752 | |
| 0.17 | 0.113 | 0.182 | Histone acetyltransferase inhibitor | 0.182 0.097 DBMET02750 0.181 0.098 DBMET02754 | DBMET02750 | |
| 0.087 | 0.03 | 0.087 | Phosphodiesterase III inhibitor | 0.078 0.037 DBMET02750 0.075 0.04 DBMET02753 0.061 0.051 DBMET02754 0.082 0.034 DBMET02755 | ||
| 0.06 | 0.004 | 0.08 | Adenosine uptake inhibitor | 0.047 0.005 DBMET02750 0.039 0.014 DBMET02753 0.045 0.007 DBMET02754 0.045 0.007 DBMET02755 0.08 0.003 DBMET02751 0.042 0.01 DBMET02752 | DBMET02751 | |
| 0.077 | 0.021 | 0.105 | Phosphodiesterase 1C inhibitor | 0.07 0.029 DBMET02750 0.093 0.013 DBMET02753 0.073 0.026 DBMET02754 0.105 0.009 DBMET02755 | DBMET02755 | |
| 0.128 | 0.074 | 0.155 | Toll-Like receptor antagonist | 0.133 0.069 DBMET02750 0.155 0.052 DBMET02753 0.119 0.086 DBMET02754 0.139 0.064 DBMET02755 | DBMET02753 | |
| 0.138 | 0.087 | 0.236 | Insulin secretagoues | 0.15 0.074 DBMET02750 0.144 0.081 DBMET02753 0.168 0.057 DBMET02754 0.142 0.083 DBMET02755 0.236 0.022 DBMET02752 | DBMET02752 | |
| 0.242 | 0.192 | 0.633 | Alpha-glucosidase inhibitor | 0.378 0.124 DBMET02750 0.334 0.143 DBMET02753 0.32 0.15 DBMET02754 0.217 0.208 DBMET02755 0.633 0.047 DBMET02752 | DBMET02752 | |
| 0.131 | 0.085 | 0.3 | Cell wall synthesis inhibitor | 0.155 0.061 DBMET02750 0.169 0.048 DBMET02753 0.216 0.024 DBMET02754 0.161 0.056 DBMET02755 0.216 0.024 DBMET02751 0.3 0.01 DBMET02752 | DBMET02752 | |
| 0.044 | 0.004 | 0.046 | Phosphodiesterase 6A inhibitor | 0.037 0.005 DBMET02750 0.04 0.004 DBMET02753 0.04 0.004 DBMET02754 0.046 0.004 DBMET02755 0.033 0.005 DBMET02751 0.023 0.018 DBMET02752 | DBMET02755 | |
| 0.04 | 0.004 | 0.041 | Phosphodiesterase 6H inhibitor | 0.036 0.005 DBMET02750 0.035 0.005 DBMET02753 0.041 0.004 DBMET02754 0.038 0.004 DBMET02755 0.033 0.005 DBMET02751 0.023 0.018 DBMET02752 | DBMET02754 | |
| 0.04 | 0.004 | 0.041 | Phosphodiesterase 6G inhibitor | 0.036 0.005 DBMET02750 0.035 0.005 DBMET02753 0.041 0.004 DBMET02754 0.038 0.004 DBMET02755 0.033 0.005 DBMET02751 0.023 0.018 DBMET02752 | DBMET02754 | |
| 0.054 | 0.018 | 0.065 | Nicotinic acid receptor 1 agonist | 0.043 0.025 DBMET02750 0.041 0.027 DBMET02753 0.065 0.014 DBMET02754 0.049 0.021 DBMET02755 | DBMET02754 | |
| 0.192 | 0.162 | 0.258 | Hypoxia-inducible factor 1 alpha inhibitor | 0.258 0.093 DBMET02750 0.209 0.141 DBMET02753 0.22 0.129 DBMET02754 0.239 0.111 DBMET02752 | DBMET02750 | |
| 0.081 | 0.054 | 0.081 | Phosphodiesterase 3A inhibitor | 0.072 0.069 DBMET02750 0.074 0.065 DBMET02755 | ||
| 0.18 | 0.154 | 0.348 | DNA synthesis inhibitor | 0.185 0.146 DBMET02750 0.174 0.163 DBMET02753 0.223 0.091 DBMET02754 0.188 0.142 DBMET02755 0.348 0.031 DBMET02752 | DBMET02752 | |
| 0.034 | 0.009 | 0.035 | DNA polymerase III inhibitor | 0.032 0.012 DBMET02750 0.033 0.01 DBMET02753 0.035 0.008 DBMET02754 0.035 0.008 DBMET02755 0.027 0.023 DBMET02751 | DBMET02755 | |
| 0.254 | 0.229 | 0.29 | MAP kinase 1 inhibitor | 0.281 0.201 DBMET02753 0.29 0.191 DBMET02755 | DBMET02755 | |
| 0.034 | 0.013 | 0.045 | NMDA 2D receptor antagonist | 0.033 0.014 DBMET02750 0.028 0.018 DBMET02753 0.043 0.009 DBMET02754 0.03 0.016 DBMET02755 0.045 0.008 DBMET02751 | DBMET02751 | |
| 0.062 | 0.041 | 0.07 | Heme oxygenase stimulant | 0.065 0.035 DBMET02750 0.058 0.051 DBMET02753 0.07 0.026 DBMET02754 0.057 0.054 DBMET02755 | DBMET02754 | |
| 0.193 | 0.178 | 0.207 | Thioredoxin glutathione reductase inhibitor | 0.207 0.166 DBMET02750 0.189 0.182 DBMET02753 0.198 0.174 DBMET02754 | DBMET02750 | |
| 0.06 | 0.046 | 0.06 | Phosphodiesterase VII inhibitor | |||
| 0.053 | 0.04 | 0.053 | Bromodomain-containing protein 4 inhibitor | |||
| 0.166 | 0.156 | 0.173 | Cardiotonic | 0.164 0.159 DBMET02753 0.173 0.148 DBMET02755 | DBMET02755 | |
| 0.051 | 0.046 | 0.052 | Phosphodiesterase II inhibitor | 0.052 0.044 DBMET02755 | DBMET02755 | |
| 0.075 | 0.072 | 0.075 | Phosphodiesterase XI inhibitor | |||
| 0.075 | 0.072 | 0.075 | Phosphodiesterase 11A inhibitor | |||
| 0.013 | 0.011 | 0.014 | DNA polymerase III polC-type inhibitor | 0.013 0.011 DBMET02753 0.013 0.01 DBMET02754 0.014 0.008 DBMET02755 | DBMET02755 | |
| 0.083 | 0.089 | 0.113 | Electrolyte absorption antagonist | 0.113 0.043 DBMET02754 | DBMET02754 | |
| 0.044 | 0.053 | 0.077 | Beta tubulin antagonist | 0.077 0.031 DBMET02750 0.049 0.048 DBMET02753 | DBMET02750 | |
| 0.028 | 0.044 | 0.032 | Tubulin agonist | 0.032 0.029 DBMET02750 | DBMET02750 | |
| 0.075 | 0.095 | 0.105 | Thioredoxin inhibitor | 0.081 0.08 DBMET02750 0.105 0.042 DBMET02752 | DBMET02752 | |
| 0.024 | 0.054 | 0.033 | Purinergic P2X3 antagonist | 0.033 0.027 DBMET02755 | DBMET02755 | |
| 0.046 | 0.082 | 0.079 | HIV-1 reverse transcriptase inhibitor | 0.079 0.043 DBMET02754 | DBMET02754 | |
| 0.069 | 0.106 | 0.08 | Interleukin 5 antagonist | 0.08 0.072 DBMET02755 0.078 0.077 DBMET02752 | DBMET02755 | |
| 0.137 | 0.177 | 0.419 | Tumour necrosis factor alpha release inhibitor | 0.16 0.146 DBMET02750 0.156 0.15 DBMET02753 0.419 0.024 DBMET02752 | DBMET02752 | |
| 0.163 | 0.204 | 0.378 | Cholesterol antagonist | 0.213 0.154 DBMET02750 0.243 0.13 DBMET02753 0.238 0.134 DBMET02754 0.22 0.148 DBMET02755 0.378 0.055 DBMET02752 | DBMET02752 | |
| 0.17 | 0.219 | 0.618 | Antithrombotic | 0.197 0.18 DBMET02750 0.196 0.182 DBMET02753 0.217 0.157 DBMET02754 0.209 0.166 DBMET02751 0.618 0.014 DBMET02752 | DBMET02752 | |
| 0.074 | 0.13 | 0.109 | Mucolytic | 0.095 0.084 DBMET02750 0.109 0.066 DBMET02752 | DBMET02752 | |
| 0.099 | 0.16 | 0.201 | Amyloid beta aggregation inhibitor | 0.201 0.077 DBMET02750 0.19 0.083 DBMET02753 0.149 0.109 DBMET02754 0.137 0.119 DBMET02752 | DBMET02750 | |
| 0.105 | 0.171 | 0.19 | Amyloid beta precursor protein antagonist | 0.13 0.127 DBMET02750 0.19 0.064 DBMET02753 0.177 0.075 DBMET02755 | DBMET02753 | |
| 0.023 | 0.092 | 0.063 | Aldose reductase inhibitor | 0.063 0.031 DBMET02752 | DBMET02752 | |
| 0.061 | 0.133 | 0.291 | Expectorant | 0.087 0.086 DBMET02750 0.291 0.009 DBMET02752 | DBMET02752 | |
| 0.151 | 0.225 | 0.579 | Transcription factor NF kappa B inhibitor | 0.241 0.134 DBMET02750 0.225 0.146 DBMET02753 0.199 0.169 DBMET02754 0.579 0.034 DBMET02752 | DBMET02752 | |
| 0.17 | 0.245 | 0.425 | Histamine release inhibitor | 0.228 0.174 DBMET02750 0.308 0.119 DBMET02753 0.272 0.14 DBMET02754 0.256 0.151 DBMET02755 0.425 0.063 DBMET02752 | DBMET02752 | |
| 0.069 | 0.145 | 0.108 | Interleukin 12 antagonist | 0.108 0.042 DBMET02752 | DBMET02752 | |
| 0.1 | 0.178 | 0.295 | Nitric oxide antagonist | 0.138 0.108 DBMET02750 0.135 0.112 DBMET02753 0.128 0.122 DBMET02751 0.295 0.041 DBMET02752 | DBMET02752 | |
| 0.06 | 0.141 | 0.107 | NADH dehydrogenase inhibitor | 0.085 0.064 DBMET02754 0.107 0.037 DBMET02752 | DBMET02752 | |
| 0.129 | 0.213 | 0.152 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.152 0.144 DBMET02750 | DBMET02750 | |
| 0.192 | 0.286 | 0.457 | Apoptosis agonist | 0.283 0.185 DBMET02750 0.274 0.191 DBMET02753 0.457 0.089 DBMET02752 | DBMET02752 | |
| 0.033 | 0.128 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.062 0.045 DBMET02750 0.067 0.041 DBMET02754 0.064 0.043 DBMET02751 | DBMET02754 | |
| 0.104 | 0.203 | 0.303 | Non-steroidal antiinflammatory agent | 0.303 0.027 DBMET02752 | DBMET02752 | |
| 0.076 | 0.176 | 0.13 | Interleukin 4 antagonist | 0.127 0.076 DBMET02750 0.13 0.072 DBMET02753 0.124 0.079 DBMET02754 0.12 0.086 DBMET02752 | DBMET02753 | |
| 0.114 | 0.223 | 0.455 | Antioxidant | 0.232 0.094 DBMET02750 0.215 0.104 DBMET02753 0.206 0.109 DBMET02754 0.195 0.117 DBMET02751 0.455 0.026 DBMET02752 | DBMET02752 | |
| 0.022 | 0.144 | 0.055 | HIV-1 integrase (Strand Transfer) inhibitor | 0.055 0.045 DBMET02751 | DBMET02751 | |
| 0.062 | 0.192 | 0.213 | Lipid peroxidase inhibitor | 0.137 0.078 DBMET02750 0.129 0.085 DBMET02753 0.132 0.082 DBMET02754 0.213 0.036 DBMET02752 | DBMET02752 | |
| 0.078 | 0.21 | 0.131 | Dual specificity phosphatase 3 inhibitor | 0.131 0.114 DBMET02753 | DBMET02753 | |
| 0.086 | 0.222 | 0.131 | Dual specificity phosphatase inhibitor | 0.131 0.119 DBMET02753 | DBMET02753 | |
| 0.049 | 0.187 | 0.087 | Ferrochelatase inhibitor | 0.087 0.086 DBMET02754 | DBMET02754 | |
| 0.027 | 0.166 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 DBMET02752 | DBMET02752 | |
| 0.041 | 0.187 | 0.144 | M18 aspartyl aminopeptidase inhibitor | 0.134 0.061 DBMET02750 0.097 0.095 DBMET02753 0.144 0.055 DBMET02754 | DBMET02754 | |
| 0.11 | 0.258 | 0.474 | Hypoglycemic | 0.181 0.132 DBMET02753 0.474 0.018 DBMET02752 | DBMET02752 | |
| 0.09 | 0.24 | 0.195 | Antiamyloidogenic | 0.151 0.146 DBMET02750 0.195 0.103 DBMET02752 | DBMET02752 | |
| 0.051 | 0.208 | 0.105 | DNA polymerase I inhibitor | 0.094 0.092 DBMET02753 0.105 0.081 DBMET02752 | DBMET02752 | |
| 0.08 | 0.242 | 0.32 | Hepatoprotectant | 0.32 0.025 DBMET02752 | DBMET02752 | |
| 0.036 | 0.197 | 0.07 | HIV-1 integrase inhibitor | 0.063 0.06 DBMET02750 0.064 0.058 DBMET02753 0.07 0.048 DBMET02754 | DBMET02754 | |
| 0.109 | 0.284 | 0.193 | 12-Lipoxygenase inhibitor | 0.193 0.159 DBMET02750 | DBMET02750 | |
| 0.04 | 0.218 | 0.103 | ATPase (Vacuolar H+) inhibitor | 0.103 0.035 DBMET02752 | DBMET02752 | |
| 0.126 | 0.308 | 0.234 | 15-Lipoxygenase inhibitor | 0.234 0.179 DBMET02750 0.215 0.196 DBMET02754 | DBMET02750 | |
| 0.039 | 0.223 | 0.148 | Topoisomerase II inhibitor | 0.148 0.05 DBMET02752 | DBMET02752 | |
| 0.08 | 0.275 | 0.402 | Free radical scavenger | 0.204 0.095 DBMET02750 0.175 0.119 DBMET02753 0.173 0.121 DBMET02754 0.402 0.028 DBMET02752 | DBMET02752 | |
| 0.152 | 0.356 | 0.611 | Cyclophilin D inhibitor | 0.264 0.197 DBMET02754 0.611 0.025 DBMET02752 | DBMET02752 | |
| 0.043 | 0.249 | 0.093 | Xanthine oxidase inhibitor | 0.093 0.068 DBMET02752 | DBMET02752 | |
| 0.068 | 0.276 | 0.203 | DNA methyltransferase I inhibitor | 0.203 0.068 DBMET02752 | DBMET02752 | |
| 0.042 | 0.25 | 0.11 | Alkylator | 0.11 0.078 DBMET02752 | DBMET02752 | |
| 0.086 | 0.305 | 0.188 | ATPase inhibitor | 0.188 0.048 DBMET02752 | DBMET02752 | |
| 0.114 | 0.335 | 0.325 | Peptidyltransferase inhibitor | 0.185 0.121 DBMET02753 0.164 0.159 DBMET02754 0.165 0.157 DBMET02755 0.325 0.017 DBMET02752 | DBMET02752 | |
| 0.068 | 0.294 | 0.249 | Aldehyde oxidase inhibitor | 0.249 0.082 DBMET02753 0.178 0.118 DBMET02755 | DBMET02753 | |
| 0.123 | 0.35 | 0.218 | GABA C receptor rho-3 antagonist | 0.218 0.186 DBMET02754 | DBMET02754 | |
| 0.122 | 0.363 | 0.202 | Caspase 3 stimulant | 0.202 0.167 DBMET02752 | DBMET02752 | |
| 0.036 | 0.279 | 0.098 | Cell adhesion molecule inhibitor | 0.098 0.036 DBMET02751 0.077 0.058 DBMET02752 | DBMET02751 | |
| 0.014 | 0.277 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET02752 | DBMET02752 | |
| 0.058 | 0.322 | 0.145 | Hexokinase inhibitor | 0.145 0.085 DBMET02752 | DBMET02752 | |
| 0.058 | 0.347 | 0.195 | DNA methylase inhibitor | 0.195 0.083 DBMET02752 | DBMET02752 | |
| 0.035 | 0.339 | 0.215 | Amylase inhibitor | 0.215 0.039 DBMET02752 | DBMET02752 | |
| 0.061 | 0.398 | 0.141 | Interferon gamma antagonist | 0.141 0.091 DBMET02752 | DBMET02752 | |
| 0.07 | 0.414 | 0.212 | Angiogenesis inhibitor | 0.212 0.156 DBMET02751 | DBMET02751 | |
| 0.023 | 0.386 | 0.083 | Creatine kinase inhibitor | 0.083 0.082 DBMET02754 | DBMET02754 | |
| 0.012 | 0.378 | 0.069 | Protein 50S ribosomal subunit inhibitor | 0.069 0.025 DBMET02752 | DBMET02752 | |
| 0.037 | 0.404 | 0.133 | Cell adhesion inhibitor | 0.133 0.057 DBMET02752 | DBMET02752 | |
| 0.034 | 0.405 | 0.439 | Angiogenesis stimulant | 0.313 0.044 DBMET02751 0.439 0.016 DBMET02752 | DBMET02752 | |
| 0.077 | 0.448 | 0.279 | Immunomodulator | 0.279 0.094 DBMET02752 | DBMET02752 | |
| 0.027 | 0.4 | 0.108 | Beta glucuronidase inhibitor | 0.108 0.059 DBMET02752 | DBMET02752 | |
| 0.05 | 0.442 | 0.161 | NOS3 expression enhancer | 0.161 0.063 DBMET02752 | DBMET02752 | |
| 0.017 | 0.423 | 0.101 | Topoisomerase I inhibitor | 0.101 0.069 DBMET02752 | DBMET02752 | |
| 0.015 | 0.45 | 0.052 | Heparanase inhibitor | 0.052 0.041 DBMET02752 | DBMET02752 | |
| 0.03 | 0.466 | 0.283 | Immunostimulant | 0.283 0.084 DBMET02752 | DBMET02752 | |
| 0.009 | 0.448 | 0.07 | Elastase inhibitor | 0.07 0.022 DBMET02751 | DBMET02751 | |
| 0.029 | 0.475 | 0.113 | Toll-Like receptor 4 antagonist | 0.113 0.051 DBMET02752 | DBMET02752 | |
| 0.04 | 0.566 | 0.338 | Immunosuppressant | 0.338 0.093 DBMET02752 | DBMET02752 | |
| 0.004 | 0.539 | 0.078 | Antineoplastic antibiotic | 0.078 0.059 DBMET02752 | DBMET02752 | |
| 0.043 | 0.586 | 0.535 | Antibacterial | 0.535 0.032 DBMET02752 | DBMET02752 | |
| 0.058 | 0.619 | 0.297 | Apoptosis antagonist | 0.297 0.087 DBMET02752 | DBMET02752 | |
| 0.027 | 0.662 | 0.089 | Transcription factor NF kappa B stimulant | 0.089 0.053 DBMET02752 | DBMET02752 | |
| 0.003 | 0.653 | 0.017 | Cholecystokinin A agonist | 0.017 0.01 DBMET02751 | DBMET02751 | |
| 0.003 | 0.654 | 0.032 | Cholecystokinin agonist | 0.032 0.009 DBMET02751 | DBMET02751 | |
| 0.039 | 0.725 | 0.514 | Antiinflammatory | 0.514 0.082 DBMET02752 | DBMET02752 | |
| 0.009 | 0.697 | 0.05 | Antibiotic Aminoglycoside-like | 0.05 0.013 DBMET02752 | DBMET02752 | |
| 0.056 | 0.77 | 0.291 | Interleukin 2 agonist | 0.291 0.08 DBMET02752 | DBMET02752 | |
| 0.017 | 0.764 | 0.177 | Platelet adhesion inhibitor | 0.177 0.084 DBMET02752 | DBMET02752 | |
| 0.003 | 0.768 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 DBMET02751 | DBMET02751 | |
| 0.007 | 0.792 | 0.047 | Cholecystokinin B agonist | 0.047 0.017 DBMET02751 | DBMET02751 | |
| 0.006 | 0.801 | 0.219 | Anticoagulant | 0.219 0.047 DBMET02751 | DBMET02751 | |
| 0.006 | 0.902 | 0.143 | Thrombolytic | 0.143 0.088 DBMET02752 | DBMET02752 | |
| 0.003 | 0.901 | 0.174 | Selectin antagonist | 0.174 0.014 DBMET02752 | DBMET02752 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |